IP Library › Granted Patent US 7,105,325
Granted Patent B2
US 7,105,325 · App. 11/029,636 · Granted Sep 12, 2006

Human hydroxylases and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,105,325
App. No.
11/029,636
Granted
Sep 12, 2006
Kind
B2
Abstract

Noval human polynucleotide and polypeptide sequences are disclosed that can be used in industrial, therapeutic, diagnostic, and pharmacogenomic applications.

Claims (20)

1. A recombinant expression vector comprising an isolated nucleic acid molecule that encodes the amino acid sequence shown in SEQ ID NO:8.

2. The recombinant expression vector of claim 1 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:7.

3. The recombinant expression vector of claim 1 , wherein said isolated nucleic acid molecule encodes the amino acid sequence shown in SEQ ID NO:6.

4. The recombinant expression vector of claim 3 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:5.

5. The recombinant expression vector of claim 3 , wherein said isolated nucleic acid molecule encodes the amino acid sequence shown in SEQ ID NO:4.

6. The recombinant expression vector of claim 5 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:3.

7. The recombinant expression vector of claim 5 , wherein said isolated nucleic acid molecule encodes the amino acid sequence shown in SEQ ID NO:2.

8. The recombinant expression vector of claim 7 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:1.

9. A host cell comprising the recombinant expression vector of claim 1 .

10. The host cell of claim 9 , wherein said recombinant expression vector comprises the nucleic acid sequence of SEQ ID NO:7.

11. The host cell of claim 9 , wherein said recombinant expression vector encodes the amino acid sequence shown in SEQ ID NO:6.

12. The host cell of claim 11 , wherein said recombinant expression vector comprises the nucleic acid sequence of SEQ ID NO:5.

13. The host cell of claim 11 , wherein said recombinant expression vector encodes the amino acid sequence shown in SEQ ID NO:4.

14. The host cell of claim 13 , wherein said recombinant expression vector comprises the nucleic acid sequence of SEQ ID NO:3.

15. The host cell of claim 13 , wherein said recombinant expression vector encodes the amino acid sequence shown in SEQ ID NO:2.

16. The host cell of claim 15 , wherein said recombinant expression vector comprises the nucleic acid sequence of SEQ ID NO:1.

17. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:8.

18. The isolated polypeptide of claim 17 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:6.

19. The isolated polypeptide of claim 18 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:4.

20. The isolated polypeptide of claim 19 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:2.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
CHANGE OF NAME Recorded Feb 24, 2022
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 059240/0463 →
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →